Imperial/Cell by Date/Implementation
From 2007.igem.org
(Difference between revisions)
(→Constitutive tetracyclin promoter) |
|||
Line 14: | Line 14: | ||
<br clear="all"> | <br clear="all"> | ||
- | ===Constitutive | + | ===Constitutive tetR Promoter=== |
<center>[[Image:Imperial CBD Design CBD1.png]]</center> | <center>[[Image:Imperial CBD Design CBD1.png]]</center> | ||
'''Ligation Strategy:''' | '''Ligation Strategy:''' | ||
Line 36: | Line 36: | ||
|''Sequence results not obtained yet'' | |''Sequence results not obtained yet'' | ||
|} | |} | ||
- | |||
===Constitutive T7 promoter=== | ===Constitutive T7 promoter=== |
Revision as of 20:50, 21 October 2007
DNA Constructs
Constitutive tetR Promoter
Ligation Strategy:
N/A
Quality Control:
Testing in vivo | Done | Results can be found at ----- |
Testing in vitro | Done | Results can be found at the testing page. |
Sequencing | Pending | Sequence results not obtained yet |
Constitutive T7 promoter
Ligation Strategy:
+ | = |
Quality Control:
Testing in vivo | Done | Results can be found at ----- |
Testing in vitro | Done | Results can be found at ----- |
Sequencing | Pending | Sequence results not obtained yet |
Chassis
cell extract preparation protocols.